Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 272

Related Citations for PubMed (Select 15879039)

1.

Device based treatment of heart failure.

Patwala AY, Wright DJ.

Postgrad Med J. 2005 May;81(955):286-91. Review.

2.

Comparison of medical therapy dosing in outpatients cared for in cardiology practices with heart failure and reduced ejection fraction with and without device therapy: report from IMPROVE HF.

Heywood JT, Fonarow GC, Yancy CW, Albert NM, Curtis AB, Gheorghiade M, Inge PJ, McBride ML, Mehra MR, O'Connor CM, Reynolds D, Walsh MN.

Circ Heart Fail. 2010 Sep;3(5):596-605. doi: 10.1161/CIRCHEARTFAILURE.109.912683. Epub 2010 Jul 15.

3.

[Recent advances and limitations of medical treatment on heart failure].

Momomura S.

Kyobu Geka. 2007 Jun;60(6):484-7. Japanese.

PMID:
17564066
4.

How well are chronic heart failure patients being managed?

Fonarow GC.

Rev Cardiovasc Med. 2006;7 Suppl 1:S3-11. Review.

PMID:
16955055
5.

[Chronic heart failure--the epidemic of the 21st century].

Czuriga I.

Orv Hetil. 2005 May 15;146(20 Suppl 2):1075-87. Review. Hungarian.

PMID:
15945236
6.

[Chronic heart failure treatment in the year 2006].

De Berrazueta Fernández JR.

An R Acad Nac Med (Madr). 2006;123(3):617-30. Review. Spanish.

PMID:
17451101
7.

Ongoing trials of cardiac resynchronisation.

Cleland JG, Ghosh J, Khan N, Hurren S, Kaye G.

Minerva Cardioangiol. 2003 Apr;51(2):197-207. Review.

PMID:
12783075
8.

Device therapy for heart failure.

Boehmer JP.

Am J Cardiol. 2003 Mar 20;91(6A):53D-59D. Review.

PMID:
12670643
9.

Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators.

Pietrasik G, Goldenberg I, McNitt S, Polonsky B, Moss AJ, Zareba W.

J Cardiovasc Electrophysiol. 2009 Apr;20(4):395-400. doi: 10.1111/j.1540-8167.2008.01333.x. Epub 2008 Oct 27.

PMID:
19017351
10.

[Management of advanced chronic heart failure].

Oliva F, Macera F, Verde A, Frigerio M.

G Ital Cardiol (Rome). 2008 Oct;9(10 Suppl 1):112S-117S. Italian.

PMID:
19195318
11.

Current role of device therapy to reduce sudden cardiac death in heart failure.

Kang S, Cannom DS.

Curr Heart Fail Rep. 2004 Sep;1(3):104-10. Review.

PMID:
16036033
12.

An approach to heart failure and diabetes mellitus.

Fonarow GC.

Am J Cardiol. 2005 Aug 22;96(4A):47E-52E. Review.

PMID:
16098844
13.

The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.

Fox M, Mealing S, Anderson R, Dean J, Stein K, Price A, Taylor RS.

Health Technol Assess. 2007 Nov;11(47):iii-iv, ix-248. Review.

14.

Strategies to improve the use of evidence-based heart failure therapies.

Fonarow GC.

Rev Cardiovasc Med. 2005;6 Suppl 2:S32-42. Review.

PMID:
15891703
15.

Implantable cardioverter-defibrillator therapy in clinical practice.

Cesario DA, Dec GW.

J Am Coll Cardiol. 2006 Apr 18;47(8):1507-17. Epub 2006 Mar 27. Review.

16.
18.

The current role of cardiac resynchronization therapy in reducing mortality and hospitalization in heart failure patients: a meta-analysis from clinical trials.

Rossi A, Rossi G, Piacenti M, Startari U, Panchetti L, Morales MA.

Heart Vessels. 2008 Jul;23(4):217-23. doi: 10.1007/s00380-008-1039-8. Epub 2008 Jul 23. Review.

PMID:
18649051
19.

Does cardiac resynchronisation therapy improve survival and quality of life in patients with end-stage heart failure?

Turley AJ, Raja SG, Salhiyyah K, Nagarajan K.

Interact Cardiovasc Thorac Surg. 2008 Dec;7(6):1141-6. doi: 10.1510/icvts.2008.183707. Epub 2008 Jun 9. Review.

20.

Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.

Bollmann A, Husser D, Cannom DS.

Am J Cardiovasc Drugs. 2005;5(6):371-8. Review.

PMID:
16259525
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk